https://www.live-feeds.com/feed/america-wants-to-make-more-generic-drugs-india-shows-why-that-s-hardContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/america-wants-to-make-more-generic-drugs-india-shows-why-that-s-hardhttps://www.live-feeds.com/feed/america-wants-to-make-more-generic-drugs-india-shows-why-that-s-hard#u102448Mon, 05 Oct 2026 11:41:34 +0000The United States has exempted generic drugs from new pharmaceutical tariffs, highlighting the severe challenges involved in shifting low-cost medicine production back to domestic soil. President Donald Trump previously announced plans for tariffs of 25% or higher on pharmaceutical and semiconductor imports, creating significant uncertainty for the Indian pharmaceutical industry. While the White House has laid the groundwork to reshore the production of 86 essential medicines, the heavy reliance on overseas manufacturing persists. India's vast cost advantages and massive production output